BMC Medicine | |
BODE-Index vs HADO-Score in Chronic Obstructive Pulmonary Disease: Which one to use in general practice? | |
Research Article | |
Luis V Basualdo1  Cristóbal Esteban1  Alberto Capelastegui1  Javier Moraza1  Myriam Aburto1  Susana Aizpiri1  José I Aguirregomoscorta1  Urko Aguirre2  José M Quintana2  | |
[1] Pneumology Department, Hospital Galdakao-Usansolo, Galdakao, Bizkaia, Spain;Research Unit-CIBER Epidemiology and Public Health (CIBERESP), Hospital Galdakao-Usansolo, Galdakao, Bizkaia, Spain; | |
关键词: Chronic Obstructive Pulmonary Disease; Chronic Obstructive Pulmonary Disease Patient; Exercise Capacity; Severe Chronic Obstructive Pulmonary Disease; Chronic Obstructive Pulmonary Disease Exacerbation; | |
DOI : 10.1186/1741-7015-8-28 | |
received in 2010-01-16, accepted in 2010-05-24, 发布年份 2010 | |
来源: Springer | |
【 摘 要 】
BackgroundForced expiratory volume in one second (FEV1) is used to diagnose and establish a prognosis in chronic obstructive pulmonary disease (COPD). Using multi-dimensional scores improves this predictive capacity.Two instruments, the BODE-index (Body mass index, Obstruction, Dyspnea, Exercise capacity) and the HADO-score (Health, Activity, Dyspnea, Obstruction), were compared in the prediction of mortality among COPD patients.MethodsThis is a prospective longitudinal study. During one year (2003 to 2004), 543 consecutively COPD patients were recruited in five outpatient clinics and followed for three years. The endpoints were all-causes and respiratory mortality.ResultsIn the multivariate analysis of patients with FEV1 < 50%, no significant differences were observed in all-cause or respiratory mortality across HADO categories, while significant differences were observed between patients with a lower BODE (less severe disease) and those with a higher BODE (greater severity). Among patients with FEV1 ≥ 50%, statistically significant differences were observed across HADO categories for all-cause and respiratory mortality, while differences were observed across BODE categories only in all-cause mortality.ConclusionsHADO-score and BODE-index were good predictors of all-cause and respiratory mortality in the entire cohort. In patients with severe COPD (FEV1 < 50%) the BODE index was a better predictor of mortality whereas in patients with mild or moderate COPD (FEV1 ≥ 50%), the HADO-score was as good a predictor of respiratory mortality as the BODE-index. These differences suggest that the HADO-score and BODE-index could be used for different patient populations and at different healthcare levels, but can be used complementarily.
【 授权许可】
CC BY
© Esteban et al; licensee BioMed Central Ltd. 2010
【 预 览 】
Files | Size | Format | View |
---|---|---|---|
RO202311103883330ZK.pdf | 855KB | download |
【 参考文献 】
- [1]
- [2]
- [3]
- [4]
- [5]
- [6]
- [7]
- [8]
- [9]
- [10]
- [11]
- [12]
- [13]
- [14]
- [15]
- [16]
- [17]
- [18]
- [19]
- [20]
- [21]
- [22]
- [23]
- [24]
- [25]
- [26]
- [27]
- [28]
- [29]
- [30]
- [31]
- [32]
- [33]
- [34]